A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Authors
Vanderweil, Stefan G.Amano, Shinya U.
Ko, Wei-Che
Richmond, Jillian M.
Kelley, Michelle
Senna, Maryanne Makredes
Pearson, Andrea
Chowdary, Sandhya
Hartigan, Celia
Barton, Bruce A.
Harris, John E.
UMass Chan Affiliations
Department of Quantitative Health SciencesDepartment of Medicine, Division of Dermatology
Document Type
Letter to the EditorPublication Date
2017-01-01
Metadata
Show full item recordAbstract
We conducted a small, randomized, double-blind, placebo-controlled, phase II clinical trial to test simvastatin as a treatment for vitiligo.Source
J Am Acad Dermatol. 2017 Jan;76(1):150-151.e3. doi: 10.1016/j.jaad.2016.06.015. Link to article on publisher's site
DOI
10.1016/j.jaad.2016.06.015Permanent Link to this Item
http://hdl.handle.net/20.500.14038/50273PubMed ID
27986135Related Resources
ae974a485f413a2113503eed53cd6c53
10.1016/j.jaad.2016.06.015